Original research: Holding back the tears: is there a role for marsupialisation?

BMJ Open Ophthalmology

article

Stephanie J Chiu¹  Zanna I Currie¹  Jennifer HY Tan¹ 

[1] Ophthalmology , Sheffield Teaching Hospitals NHS Foundation Trust

关键词: Lacrimal drainage;    Treatment Surgery;    Eye Lids;    Neoplasia;   

DOI  :  10.1136/bmjophth-2022-000985

学科分类：工业工程学

来源: BMJ Publishing Group

【 摘 要 】

Objective Medial eyelid tumours may result in the loss of the proximal lacrimal system during staged excision and delayed reconstruction, to achieve tumour margin clearance. The remnant canaliculus was marsupialised during reconstruction. The aim was to understand how many patients experienced symptomatic epiphora as a consequence of this.Methods and analysis A retrospective study including patients over a 15-year period with medial eyelid tumours, where the proximal lacrimal system was sacrificed to achieve tumour margin clearance. Included were all who had marsupialisation of the remnant distal stump as part of their delayed reconstruction. All who had pre-existing epiphora were excluded. The primary objective was the rate of epiphora following the procedure. A systematic literature review of postoperative epiphora occurring in patients with lid tumours requiring lacrimal system injury/sacrifice during tumour excision.Results There were 22 eyes (22 patients). All were basal cell carcinomas except for 1 (4.5%) tarsal conjunctival squamous cell carcinoma. All cases involved the lower lid. There were two (9.1%) patients who developed epiphora. One patient underwent a superior three-snip punctoplasty, botulinum toxin to the lacrimal gland and conjunctivodacryocystorhinostomy with Lester Jones tube insertion. The other patient was not overly troubled and did not require further treatment. The literature review showed the median postoperative rate of epiphora in these patients was 12.5% (range 0%–100%).Conclusion Marsupialisation of the remnant canaliculus during delayed reconstruction is a straightforward and effective surgical option, which may help prevent postreconstruction epiphora when the proximal lacrimal system is sacrificed for tumour margin clearance.Trial registration number 10391.

【 授权许可】

CC BY-NC|CC BY|CC BY-NC-ND